Erratum: Assessing the dual activity of a chalcone-phthalocyanine conjugate: Design, synthesis, and antivascular and photodynamic properties (Molecular Pharmaceutics (2013) 10:10 (3706-3716) DOI: 10.1021/mp400207v);Assessing the dual activity of a chalcone-phthalocyanine conjugate: Design, synthesis, and antivascular and photodynamic properties

Molecular Pharmaceutics

Volumn 10, Issue 10, 2013, Pages 3706-3716

  Tuncel, Sinem ^a   Trivella, Aurélien ^b,c   Atilla, Devrim ^a   Bennis, Khalil ^b   Savoie, Huguette ^d   Albrieux, Florian ^e   Delort, Laetitia ^f   Billard, Hermine ^f   Dubois, Virginie ^f   Ahsen, Vefa ^a   Caldefie Chézet, Florence ^f   Richard, Claire ^b,c   Boyle, Ross W ^d   Ducki, Sylvie ^b,c   Dumoulin, Fabienne ^a  

^a GEBZE TECHNICAL UNIVERSITY   (Turkey)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c ICCF   (France)

^d UNIVERSITY OF HULL   (United Kingdom)

^e UNIVERSITÉ LYON 1   (France)

^f INRA and University of Auvergne   (France)

Author keywords

Antivascular; Chalcone; Dual effect; Photodynamic therapy; Phthalocyanine

Indexed keywords

CHALCONE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; VASCULAR TARGETING AGENT;

ABSORPTION SPECTROSCOPY; ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CARBON NUCLEAR MAGNETIC RESONANCE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DESIGN; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ENDOTHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHILICITY; LD 50; LD 90; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID TUMOR; ULTRAVIOLET SPECTROSCOPY;

CELL LINE; CELL MOVEMENT; CHALCONE; HUMANS; INDOLES; MOLECULAR STRUCTURE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SINGLET OXYGEN;

EID: 84888375498     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5008426     Document Type: Erratum

References (41)

1. (a) Tirand, L.; Frochot, C.; Vanderesse, R.; Thomas, N.; Trinquet, E.; Pinel, S.; Viriot, M.-L.; Guillemin, F.; Barberi-Heyob, M. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells. J. Controlled Release 2006, 111, 153-164.
2. (b) Thomas, N.; Pernot, M.; Vanderesse, R.; Becuwe, P.; Kamarulzaman, E.; Da Silva, D.; François, A.; Frochot, C.; Guillemin, F.; Barberi-Heyob, M. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties. Biochem. Pharmacol. 2010, 80, 226-235.
3. (c) Kwitniewski, M.; Juzeniene, A.; Glosnicka, R.; Moan, J. Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy? Photochem. Photobiol. Sci. 2008, 7, 1011-1017.
4. (d) Fabbrini, M.; Trachsel, E.; Soldani, P.; Bindi, S.; Alessi, P.; Bracci, L.; Kosmehl, H.; Zardi, L.; Neri, D.; Neri, P. Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate. Int. J. Cancer 2006, 118, 1805-1813.
5. (a) Sawant, R. R.; Torchilin, V. P. Liposomes as 'smart' pharmaceutical nanocarriers. Soft Matter 2010, 6, 4026-4044.
6. (b) Zhao, B.; Yin, J.-J.; Bilski, P. J.; Chignell, C. F.; Roberts, J. E.; He, Y.-Y. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol. Appl. Pharmacol. 2009, 241, 163-172.
7. (c) Xiao, L.; Gu, L.; Howell, S. B.; Sailor, M. J. Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano 2011, 5, 3651-3659.
8. (d) Wacker, M.; Chen, K.; Preuss, A.; Possemeyer, K.; Roeder, B.; Langer, K. Photosensitizer loaded HSA nanoparticles I: Preparation and photophysical properties. Int. J. Pharm. 2010, 393, 253-263.
9. (e) Preuss, A.; Chen, K.; Hackbarth, S.; Wacker, M.; Langer, K.; Roeder, B. Photosensitizer loaded HSA nanoparticles II: In vitro investigations. Int. J. Pharm. 2011, 404, 308-316.
10. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 2001, 41, 189-207.
11. (a) Ducki, S.; Rennison, D.; Woo, M.; Kendall, A.; Fournier Dit Chabert, J.; McGown, A. T.; Lawrence, N. J. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity. Bioorg. Med. Chem. 2009, 17, 7698-7710.
12. (b) Ducki, S.; Mackenzie, G.; Greedy, B.; Armitage, S.; Fournier Dit Chabert, J.; Bennett, E.; Nettles, J.; Snyder, J. P.; Lawrence, N. J. Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: Structure-based discovery of alpha-aryl chalcones. Bioorg. Med. Chem. 2009, 17, 7711-7722.
13. (c) Ducki, S. The development of chalcones as promising anticancer agents. IDrugs 2007, 10, 42-46.
14. (d) Lippert, J. W., III Vascular disrupting agents. Bioorg. Med. Chem. 2007, 15, 605-615.
15. (e) Mason, R. P.; Zhao, D.; Liu, L.; Trawick, M. L.; Pinney, K. G. A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment. Integr. Biol. 2011, 3, 375-387.
16. Prise, V. E.; Honess, D. J.; Stratford, M. R.; Wilson, J.; Tozer, G. M. The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses. Int. J. Oncol. 2002, 21, 717-726.
17. Siemann, D. W. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. Cancer Treat. Rev. 2011, 37, 63-74.
18. Tuncel, S.; Fournier-dit-Chabert, J.; Albrieux, F.; Ahsen, V.; Sylvie Ducki, S.; Dumoulin, F. Towards dual photodynamic and antiangiogenic agents: design and synthesis of a phthalocyanine-chalcone conjugate. Org. Biomol. Chem. 2012, 10, 1154-1157.
19. (a) Dumoulin, F.; Durmuş, M.; Ahsen, V.; Nyokong, T. Synthetic pathways to water-soluble phthalocyanines. Coord. Chem. Rev. 2010, 254, 2792-2847.
20. (b) Atilla, D.; Saydan, N.; Durmuş, M.; Gürek, A. G.; Khan, T.; Rück, A.; Walt, H.; Nyokong, T.; Ahsen, V. Synthesis and photodynamic potential of tetra-and octa-triethyleneoxysulfonyl substituted zinc phthalocyanines. J. Photochem. Photobiol., A 2007, 186, 298-307.
21. Tuncel, S.; Dumoulin, F.; Gailer, J.; Sooriyaarachchi, M.; Atilla, D.; Durmuş, M.; Bouchu, D.; Savoie, H.; Boyle, R. W.; Ahsen, V. A set of highly water-soluble tetraethyleneglycol-substituted Zn(II] phthalocyanines: synthesis, photochemical and photophysical properties, interaction with plasma proteins and in vitro phototoxicity. Dalton Trans. 2011, 40, 4067-4079.
22. Zorlu, Y.; Ermeydan, M. A.; Dumoulin, F.; Ahsen, V.; Savoie, H.; W. Boyle, R. W. Glycerol and Galactose Substituted Zinc Phthalocyanines. Synthesis and Photodynamic Activity. Photochem. Photobiol. Sci. 2009, 8, 312-318.
23. (a) Josefsen, L. B.; Boyle, R. W. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2012, 2, 916-966.
24. (b) Dumoulin, F.; Ali, H.; Ahsen, V.; van Lier, J. E. Preparation of amphiphilic glycerol-substituted zinc phthalocyanines using copperfree Sonogashira cross-coupling in aqueous medium. Tetrahedron Lett. 2011, 52, 4395-4397.
25. (c) Bronshtein, I.; Afri, M.; Weitman, H.; Frimer, A. A.; Smith, K. M.; Ehrenberg, B. Porphyrin Depth in Lipid Bilayers as Determined by Iodide and Parallax Fluorescence Quenching Methods and Its Effect on Photosensitizing Efficiency. Biophys. J. 2004, 87, 1155-1164.
26. (a) Karasawa, A.; Ito, N. Electrophotographic green toners using specific phthalocyanine-type dye. Mitsui Toatsu Chemicals, Japan, JP 05257322, 1993.
27. (b) Kobayashi, N.; Higashi, R.; Ishii, K.; Hatsusaka, K.; Ohta, K. Aggregation, complexation with guest molecules, and mesomorphism of amphiphilic phthalocyanines having four-or eight tri(ethylene oxide) chains. Bull. Chem. Soc. Jpn. 1999, 72, 1263-1271.
28. Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory Chemicals, 2nd ed.; Pergamon Press: Oxford, 1989.
29. Jarde, T.; Caldefie-Chezet, F.; Goncalves-Mendes, N.; Mishellany, F.; Buechler, C.; Penault-Llorca, F.; Vasson, M. P. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr.-Relat. Cancer 2009, 16, 1197-1210.
30. O'Brien, J.; Wilson, I.; Orton, T.; Pognan, F. Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267, 5421-5426.
31. Dubois, V.; Delort, L.; Billard, H.; Vasson, M.; Caldefie-Chezet, F. Breast cancer and obesity: in vitro interferences between adipokines and proangiogenic features and/or antitumor therapies? PLoS ONE 2013, 8, e58541 DOI: 10.1371/journal.pone.0058541.
32. (a) Sato, Y.; Rifkin, D. B. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell Biol. 1988, 107, 1199-1205.
33. (b) Hulkower, K.; Herber, R. L. Cell Migration and Invasion Assays as Tools for Drug Discovery. Pharmaceutics 2011, 3, 107-124.
34. Krieg, M. Determination of singlet oxygen quantum yields with 1, 3-diphenylisobenzofuran in model membrane systems. J. Biochem. Biophys. Methods 1993, 27, 143-149.
35. Reddi, E.; Valduga, G.; Rodgers, M. A. J.; Jori, G. Studies on the mechanism of the hematoporphyrin-sensitized photooxidation of 1, 3-diphenylisobenzofuran in methanol and unilamellar liposomes. Photochem. Photobiol. 1991, 54, 633-637.
36. Spiller, W.; Kliesch, H.; Wöhrle, D.; Hackbarth, S.; Röder, B.; Schnurpfeil, G. Singlet oxygen quantum yields of different photosensitizers in polar solvents and micellar solutions. J. Porphyrins Phthalocyanines 1998, 2, 145-158.
37. Seotsanyana-Mokhosi, I.; Kuznetsova, N.; Nyokong, N. Photochemical studies of tetra-2, 3-pyridinoporphyrazines. J. Photochem. Photobiol., A 2001, 140, 215-222.
38. Esenpinar, A. A.; Durmus., M.; Bulut, M. Synthesis and properties of crown ether functionalized coumarin substituted zinc phthalocyanine. Polyhedron 2011, 30, 2067-2074.
39. Gorman, A. A.; Rodgers, M. A. J. In Handbook of Organic Photochemistry; Scaiano, J. C., Ed.; CRC Press: Boca Raton, FL, 1989; Vol. II, pp 229-250.
40. Wilkinson, F.; Brummer, J. G. Rate constants for the decay and reactions of the lowest electronically excited singlet state of molecular oxygen in solution. J. Phys. Chem. Ref. Data 1981, 10, 809-999.
41. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxocity assays. J. Immunol. Methods 1983, 65, 55-63.